Perspectives
Drug Pipeline Quarterly Update: December 2020
Drugs in review, drugs with expiring patents, generic availability and more.
December 30, 2020These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.
Related news
Perspectives
March 29, 2024
Executive Viewpoint: Dr. Meredith Delk reflects on Women’s History Month and social disparities in health care
By Meredith Delk, PhD, MSW, Senior Vice President and General Manager, State Government…
Perspectives
March 27, 2024
Drug Approvals Monthly Update: March 2024
Critical updates in an ever-changing environment
Perspectives
March 27, 2024
Clinical News: March 2024
Your monthly source for drug information highlights